Ibrance

Ibrance Coupons & Discount Card – Guaranteed Prices from $23414.08

Palbociclib, commercially known as Ibrance, is a medication designed to treat certain types of advanced or metastatic breast cancer, specifically HR+/HER2- breast cancer. This drug works by inhibiting cyclin-dependent kinases 4 and 6 (CDK 4/6), proteins that can become overactive and lead to the uncontrolled growth of cancer cells. By blocking these proteins, palbociclib effectively slows down the progression of cancer. It is typically administered orally once a day for 21 consecutive days, followed by a 7-day break, repeating this cycle every 28 days. Importantly, palbociclib should be used alongside other treatments that reduce or block estrogen levels in the body. Always consult your healthcare provider for personalized medical advice before starting any new treatment.
Our Ibrance coupons are free to use. You can print the coupon, email it to yourself, or receive the Ibrance coupon via text message. To get your free discount, show the pharmacist your Ibrance savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Ibrance prices will update based on your prescription needs. Above our Ibrance coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Ibrance savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

100MG, Ibrance (30 Capsules)

Select pharmacy

Pharmacy logo

Rite Aid

$23414.08

COUPON PRICE
Pharmacy logo

Walgreens

$24402.79

COUPON PRICE

Ibrance savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$23414.08

BIN

ID

PCN

GRP

019876

LH03D95EE7

CHIPPO

LHX

Powered by

This card is not insurance

Related kinase inhibitors prescriptions

coupons from$6591.53Save 72%
coupons from$5210.34Save 72%
coupons from$9738.74 
coupons from$5406.21Save 74%
coupons from$20961.09Save 72%
coupons from$12702.07 
coupons from$7738.15Save 72%
coupons from$22822.87 

More prescriptions for breast cancer

coupons from$6654.05 
coupons from$355.47Save 61%
coupons from$662.52Save 73%
coupons from$944.28 
coupons from$7.44Save 87%
coupons from$44.8Save 94%
coupons from$8Save 92%
coupons from$1876.86Save 74%

Related kinase inhibitors prescriptions

Rydapt Save 72%coupons from $6591.53
Bosulif Save 72%coupons from $5210.34
Xospatacoupons from $9738.74
Sprycel Save 74%coupons from $5406.21
Alunbrig Save 72%coupons from $20961.09
Tepmetkocoupons from $12702.07
Tavalisse Save 72%coupons from $7738.15
Iclusigcoupons from $22822.87

More prescriptions for breast cancer

Tukysacoupons from $6654.05
Toremifene Save 61%coupons from $355.47
Soltamox Save 73%coupons from $662.52
Herceptin Hylectacoupons from $944.28
Tamoxifen Save 87%coupons from $7.44
Faslodex Save 94%coupons from $44.8
Letrozole Save 92%coupons from $8
Methitest Save 74%coupons from $1876.86

Ibrance dosage forms

The average cost for 30 Capsules of Ibrance at 75MG is $23707.03 with a free coupon. This is 72% off the average retail price of $84851.03
DosageQuantityPrice fromPer unit
75MG30 Capsules$23707.03$790.23
100MG30 Capsules$23707.03$790.23
125MG30 Capsules$23707.03$790.23

Ibrance Warnings

The following safety information highlights crucial risks and precautions associated with the use of Ibrance (palbociclib). For your safety, please review these details carefully and discuss any concerns with your healthcare provider.

  • Low White Blood Cell Counts: Ibrance (palbociclib) may lead to a decrease in white blood cell counts, increasing the risk of infections. Regular blood monitoring is essential during treatment. Contact your healthcare provider immediately if you experience fever or illness, as dosage adjustments or discontinuation may be necessary.

  • Lung Issues: Although rare, Ibrance (palbociclib) can cause severe lung conditions, such as lung inflammation or interstitial lung disease. Report any new or worsening respiratory symptoms, such as shortness of breath, dry cough, or rapid breathing, to your healthcare provider. Temporary cessation of the drug may be required to determine the cause of these symptoms.

  • Potential Harm to Unborn Babies: Animal studies suggest that Ibrance (palbociclib) may cause harm to an unborn child. Women of childbearing potential should employ effective contraception during treatment and for at least three weeks after the last dose. Men with female partners of childbearing potential should use contraception during treatment and for three months post-treatment. Notify your healthcare provider immediately if pregnancy occurs during this period.

Please note that there are no specific contraindications identified for this medication. Always follow your healthcare provider’s recommendations and report any unusual symptoms or concerns promptly.

Ibrance Side Effects

This medication may cause several side effects, some of which are common and mild, while others are rare but more serious. Common side effects include nausea, vomiting, diarrhea, loss of appetite, tiredness, hair loss, and mouth sores. You might also experience numbness or tingling in your arms or legs, weakness, or changes in taste. These symptoms are often manageable, but if they persist or worsen, it's important to consult your healthcare provider.

Additionally, some patients may experience low blood cell counts, which can lead to symptoms such as fatigue, pale skin, or easy bruising and bleeding. Infections are another possible side effect, with symptoms like fever, chills, sore throat, or cough. It's important to be alert to these signs as this medication can lower your body's ability to fight infections.

Rare but serious side effects require immediate medical attention. These include severe allergic reactions, characterized by rash, itching, swelling, severe dizziness, or trouble breathing. Serious lung problems, such as chest pain and shortness of breath, also necessitate urgent care. If you encounter any unusual symptoms or side effects not listed here, contact your healthcare provider for advice.

Ibrance Interactions

Certain medications can influence how your body processes palbociclib, potentially altering its effectiveness. Drugs such as azole antifungals (including itraconazole and ketoconazole), carbamazepine, phenytoin, rifamycins (like rifampin), and the herbal supplement St. John's wort are known to affect the removal of palbociclib from the body.
Ibrance FAQs
Is Ibrance a form of chemotherapy?

Ibrance is not considered traditional chemotherapy. It is a targeted therapy known as a CDK4/6 inhibitor, which works by interfering with specific proteins involved in the growth and division of cancer cells. It is often used in combination with other treatments for certain types of breast cancer.

Ibrance is used in the treatment of certain types of breast cancer. It is typically prescribed for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, often in combination with hormone therapy.

The most common side effect of Ibrance (palbociclib) is neutropenia, which is a decrease in the number of neutrophils, a type of white blood cell important for fighting infections.

Ibrance side effects can vary in duration and intensity among individuals. Some side effects may diminish as the body adjusts to the medication, while others might persist throughout the treatment. Common side effects like fatigue, nausea, and hair thinning may improve over time. However, more serious side effects, such as low blood cell counts, require monitoring and may necessitate medical intervention. It is important for patients to discuss any persistent or concerning side effects with their healthcare provider to manage them effectively.

Yes, Ibrance (palbociclib) is considered a type of targeted cancer therapy, which is a form of chemotherapy. It specifically targets certain proteins in cancer cells to inhibit their growth and proliferation.